Sabra Health Care REIT, Inc. (SBRA) Institutional Ownership & Insider Trading

463 institutions reported holding Sabra Health Care REIT, Inc. shares in 13F filings for the quarter ended 2026-06-30, according to EquiReason's reading of their SEC filings. 2 insider trades on Form 4 since 2025-10-01.

Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason

SBRASabra Health Care REIT, Inc.Follow SBRA — free

REIT - Healthcare Facilities · Real Estate

—

Price chart with a free account

Market cap: 5.0B
P/E TTM: 75.2
Dividend yield: 6.1%
52-week: —
Next earnings: 2 Nov, in 9 days

Institutions · all 13F filers

quarter to 30 Jun 2026 · filers in both quarters

463 institutions held —% of the shares. Across filers that reported both quarters, shares held changed +0.4%.

Largest moves, shares (millions)

Institutional flow by quarter

net shares added or trimmed, millions · filers in both quarters

Quarter	Holders	Shares held, M	Change	Increased	New	Decreased	Closed
Jun 26	463	261	+0.4%	151	36	134	30
Mar 26	457	258	+2.3%	170	49	121	29
Dec 25	428	255	+7.4%	155	51	105	40
Sep 25	410	235	+2.5%	147	46	95	20
Jun 25	386	232	+1.9%	136	32	110	35
Mar 25	391	223	-1.8%	141	38	95	31
Dec 24	378	229	-3.2%	134	30	85	32
Sep 24	366	222	+5.9%	116	41	89	20

Sabra Health Care REIT, Inc. — questions

Who owns Sabra Health Care REIT, Inc. stock?: 463 institutions reported Sabra Health Care REIT, Inc. shares in 13F filings for the quarter ended 2026-06-30. The largest: BlackRock, Inc. (16.3%), PRINCIPAL FINANCIAL GROUP INC (9.7%), VANGUARD PORTFOLIO MANAGEMENT LLC (9.1%).
Are Sabra Health Care REIT, Inc. insiders buying or selling?: 2 insider trades on Form 4 since 2025-10-01; the full list, with dates, people and plan status, is on this page.

Every figure on this page comes from Sabra Health Care REIT, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.

How these figures are read: methodology · EquiReason.

Important information. Figures on this page are taken from filings submitted to the U.S. Securities and Exchange Commission (SEC) and processed automatically by EquiReason. They may contain errors, omissions or delays, and EquiReason makes no representation or warranty as to their accuracy, completeness or timeliness. Always verify figures against the original filing on SEC EDGAR before relying on them.

This page is provided for general information and educational purposes only. It does not constitute investment, financial, legal or tax advice, and it is not a recommendation or an offer to buy, sell or hold any security. It does not take into account your objectives, financial situation or needs. Past performance does not guarantee future results; any reliance on this information is at your own risk. See our Disclaimer and Risk Disclosure.